Want to see TTRX full AI Analyst Report?
Total Valuation
Turn Therapeutics Inc has a market cap or net worth of $281.79M. The enterprise value is $213.29.
Market Cap$281.79M
Enterprise Value$213.29
Share Statistics
Turn Therapeutics Inc has 29,788,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,788,040
Owned by Insiders59.05%
Owned by Institutions0.71%
Financial Efficiency
Turn Therapeutics Inc’s return on equity (ROE) is -0.68 and return on invested capital (ROIC) is -94.42%.
Return on Equity (ROE)-0.68
Return on Assets (ROA)-0.26
Return on Invested Capital (ROIC)-94.42%
Return on Capital Employed (ROCE)-0.95
Revenue Per Employee0.00
Profits Per Employee-1.60M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Turn Therapeutics Inc is ―. Turn Therapeutics Inc’s PEG ratio is -0.22.
PE Ratio―
PS Ratio0.00
PB Ratio11.55
Price to Fair Value11.55
Price to FCF-19.94
Price to Operating Cash Flow-65.21
PEG Ratio-0.22
Income Statement
In the last 12 months, Turn Therapeutics Inc had revenue of 0.00 and earned -3.19M in profits. Earnings per share was -0.23.
Revenue0.00
Gross Profit0.00
Operating Income-5.86M
Pretax Income-3.19M
Net Income-3.19M
EBITDA-3.14M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was -4.32M and capital expenditures -2.00, giving a free cash flow of -4.32M billion.
Operating Cash Flow-4.32M
Free Cash Flow-4.32M
Free Cash Flow per Share-0.15
Dividends & Yields
Turn Therapeutics Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.70
52-Week Price Change2.83%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)2.86M
Important Dates
Turn Therapeutics Inc upcoming earnings date is Nov 12, 2026, Before Open (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Turn Therapeutics Inc as a current ratio of 0.87, with Debt / Equity ratio of 891.13%
Current Ratio0.87
Quick Ratio0.87
Debt to Market Cap0.00
Net Debt to EBITDA1.59
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Turn Therapeutics Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Turn Therapeutics Inc EV to EBITDA ratio is -15.65, with an EV/FCF ratio of -18.10.
EV to Sales0.00
EV to EBITDA-15.65
EV to Free Cash Flow-18.10
EV to Operating Cash Flow-19.18
Balance Sheet
Turn Therapeutics Inc has $10.29M in cash and marketable securities with $6.12M in debt, giving a net cash position of $4.17M billion.
Cash & Marketable Securities$10.29M
Total Debt$6.12M
Net Cash$4.17M
Net Cash Per Share$0.14
Tangible Book Value Per Share$0.27
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Turn Therapeutics Inc is $16.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$16.00
Price Target Upside483.94% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―